TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Substantial Neonatal Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Days on Therapy (DOT) with antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of TIL therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants With HIV-1 RNA ≥ 50 Copies/mL at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of Participants With HIV-1 RNA ≥ 50 Copies/mL at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: invasive Disease-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Time to obtain the CVS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number and types of proteins/peptides differential characteristic peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Job satisfaction at work
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Emotional exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Autonomy and competence satisfaction and frustration at work
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Intraclass correlation coefficient (ICC) between SECMOO2 and ScVO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Expression Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Clinical Response (MCR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life - Work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prevalence of Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Concept maps
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants with Combined remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal responsiveness of Longshi Scale at discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Internal responsiveness of Barthel Index at discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Internal responsiveness of Longshi Scale at 3 months after discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Internal responsiveness of Barthel Index at 3 months after discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life (EQ5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mental Wellbeing (WEMWBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frailty (CESAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EBV-DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PTLD incidence
Endpoint domain: Adverse events/effects
Primary endpoint: BDNF level in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Surgeons Approached Who Agree to Participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Patients Contacted Who Agree to Participate in Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Surgeon-reported Acceptability of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Visual analogue scale (VAS) for night pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematocrit Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Heavy Drinking Episode Days in the Past 30 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Drinks Per Week in the Past 30 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain, Enjoyment of Life, General Activity (PEG) Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: liver fibrosis progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Pain scores at admission to PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at discharge from hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of time remaining above pH 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hospitalization due to worsening of heart failure or acute coronary syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Level of vigilance measured by change in the Glasgow Coma Scale (GCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of device-related Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in WHO risk level via 28-day TLFB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Global Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UPDRS III (Unified Parkinson's Disease Rating Scale part 3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Inflammatory response in ocular surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Conjunctival cell phenotype and inflammatory infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in oxidative stress in the tear film
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days to Healing of the Superficial Partial Thickness Burn Wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Screening Visit to Visit 8 in Total Patient and Observer Scar Assessment Scale (POSAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: MEG physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECG physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No Food Due to Lack of Money
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: No Water Due to Difficulty Collecting
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Going to Sleep Hungry
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Going to Sleep Thirsty
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: No Food for Entire Day
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Drink Unsafe Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of pathologic complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Delirium Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of restorative materials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of sarcopenia: muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of sarcopenia: muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of sarcopenia: changes in muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of sarcopenia: changes in muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of sarcopenia: changes in muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Metabolic Decompensation Events (MDEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total days of use of opioids, stimulants, and alcohol heavy drinking
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Highest dose of radiation to the rectum and bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiological outcomes
Primary endpoint: Histotripsy Technical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loop Gain (LG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean in-shoe PPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental and physical performance profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain health baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Difficult Cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of days lost due to unplanned cardiovascular hospitalizations
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of days lost due to death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival Rate at Month 12
Endpoint domain: Mortality/survival
Primary endpoint: beta estradiol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: TNF alpha level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Study product-related, biopsy procedure-related, and injection procedure-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Anterior tongue pressure measured from Iowa Oral Performance Instrument (IOPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody avidity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ONCO CTC expression pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunological Aging Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biological Aging Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral performance of the video game task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the BCI classifier output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive assessment I: Montreal Cognitive Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: muscle mitochondrial oxidative capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean monocular postoperative DCIVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of eyes that achieve 0.3, 0.2, 0.1 and 0.0 logMAR monocular DCIVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG slow wave activity (uV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal fluid flow (ml/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beta-amyloid (pg/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Mini Mental State Examination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in the incidence, nature and severity of AE's and SAE's
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in enzyme β-Glucocerebrosidase (GCase) concentration levels in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to all-cause unplanned hospital visit after discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pain: VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibromyalgia Impact Questionnaire (S-FIQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NGAL values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Whole-Body Intermuscular Adipose Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of No Jump Burpees to Exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient and clinician adherence to guidelines
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Plasma concentration of MDMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of active metabolite MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Birth Process
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: ABC scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acute changes in left ventricular mechanical synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute changes in left ventricular regional wall motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute changes in left ventricular end-diastolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in parent-child interaction synchrony
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cost implications of surgical modalities
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Wound Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemoglobin glycated (Hb1Ac) mean changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of anastomotic leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Disease relapse and biochemical remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side-effects of steroids
Endpoint domain: Adverse events/effects
Primary endpoint: Pediatric Quality of Life Inventory (PedsQL 4.0) Generic Core Scales Short Form 15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients who require hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: cost-effectiveness of antimicrobial stewardship program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Covid-19 seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tissue-to-blood ratio of the most-diseased segment of the ascending aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Families screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Site Participation Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ethnic minority families screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Participants Who Experienced a Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in disease and symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder Flexibility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Trunk Rotation Flexibility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Shoulder range of motion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Elbow range of motion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Figure of eight walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery at Day 90
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Strength of Respiratory Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Door-to-Needle time for intravenous thrombolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting numerical rating scale (NRS) pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest Serum Creatinine Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cognitive function: Multitasking test (MTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function: The spatial working memory (SWM) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Abdomino-Pelvic Pain Intensity (APPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstruation-Related Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milk to plasma ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life according to QLQ-C15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: quality of life according to BN-20
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Skindex-29 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes of Unified Parkinson's Disease Rating Scale (UPDRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of brain plasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of circulating serum level of inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient abstinence from opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mixed venous oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in DAS-28-CRP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Multidimensional Health Assessment Questionnaire (MDHAQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients completing the exercise intervention sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gingival bleeding on probing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of participants with solicited local and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Numbers of participants reporting Unsolicited AEs and medically attended adverse events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with MAAEs, SAEs, AESIs (including [PIMMCs] and myocarditis and/or pericarditis)
Endpoint domain: Adverse events/effects
Primary endpoint: Level of fatigue experienced after VR experience
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Seroconversion rate of the neutralizing antibody to live SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate of the neutralizing antibody to EV71
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Aneurysm Occlusion of the Treated Target Lesion on 6 Month Angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of major ipsilateral stroke or neurological death
Endpoint domain: Mortality/survival
Primary endpoint: Number of lower Respiratory Tract Infections (RTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of wheezing episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Visual Analogue Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pregnant women's quality of life questionnaire (QOL-GRAV)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Visual Analogue Scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complications measured by the comprehensive complication index
Endpoint domain: Adverse events/effects